Exosome-like extracellular vesicles from MYCN-amplified neuroblastoma cells contain oncogenic miRNAs

Anticancer Research

Volumn 35, Issue 5, 2015, Pages 2521-2530

  Haug, Bjørn Helge ^a   Hald, Øyvind H ^b   Utnes, Peter ^a   Roth, Sarah A ^b   Løkke, Cecilie ^b   Flægstad, Trond ^a,b   Einvik, Christer ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Exosome; MicroRNA; miRNA; Neuroblastoma

Indexed keywords

CD63 ANTIGEN; MICRORNA; MICRORNA 125B; MICRORNA 16; MICRORNA 21; MICRORNA 218; MICRORNA 23A; MICRORNA 24; MICRORNA 25; MICRORNA 27B; MICRORNA 320A; MICRORNA 320B; MICRORNA 92A; NANOPARTICLE; ONCOGENIC MICRORNA; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; MESSENGER RNA; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TLR8 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; EXOSOME; EXOSOME LIKE EXTRACELLULAR VESICLE; GENE AMPLIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA CELL; ONCOGENE; ONCOGENE MYCN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SHORT TANDEM REPEAT; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 8;

EID: 84929663700     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007.
2. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M and Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248, 1983.
3. Cheung L, Murray JE, Haber M and Norris MD: The MYCN Oncogene. In: Oncogene and Cancer-From Bench to Clinic. Siregar Y (ed.). InTech, pp 437-454, 2013.
4. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
5. Chen Y and Stallings RL: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67: 976-983, 2007.
6. Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T and Einvik C: Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Differentiation 81: 25-34, 2011.
7. Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S and Henriksson M: MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci USA 107: 1553-1558, 2010.
8. Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, Milosavljevic A, Kim ES and Gunaratne PH: A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res 71: 3841-3851, 2011.
9. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J and Weinberg R a: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
10. Buechner J and Einvik C: N-myc and Noncoding RNAs in Neuroblastoma. Mol Cancer Res: 1243-1253, 2012.
11. Bobrie A, Colombo M, Raposo G and Théry C: Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12: 1659-1668, 2011.
12. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
13. Raposo G and Stoorvogel W: Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373-383, 2013.
14. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D and Croce CM: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 109: E2110-2116, 2012.
15. Cervantes JL, Weinerman B, Basole C and Salazar JC: TLR8: the forgotten relative revindicated. Cell Mol Immunol 9: 434-438, 2012.
16. Squadrito ML, Baer C, Burdet F, Maderna C, Gilfillan GD, Lyle R, Ibberson M and De Palma M: Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells. Cell Rep: 1-15, 2014.
17. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, Lochnit G, Preissner KT and Zöller M: Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70: 1668-1678, 2010.
18. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D and Ferrara N: Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J: 1-11, 2012.
19. Umezu T, Ohyashiki K, Kuroda M and Ohyashiki JH: Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene: 1-9, 2012.
20. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia B a, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J and Lyden D: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18: 883-891, 2012.
21. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and Wrana JL: Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151: 1542-1556, 2012.
22. Kogure T, Lin W-L, Yan IK, Braconi C and Patel T: Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54: 1237-1248, 2011.
23. Kosaka N, Iguchi H, Yoshioka Y, Hagiwara K, Takeshita F and Ochiya T: Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 287: 1397-1405, 2012.
24. Mitchell JP, Court J, Mason MD, Tabi Z and Clayton A: Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J Immunol Methods 335: 98-105, 2008.
25. Life Technologies: Certificate of analysis. 887799: 1, 2011. Available from: http://tools.lifetechnologies.com/Content/SFS/COAPDFs/2011/887799-C0155C.pdf.
26. Rani S, Brien KO, Kelleher FC, Corcoran C, Germano S, Radomski MW, Crown J and Driscoll LO: Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profilin. In: Methods. O'Driscoll L (ed.). Totowa, NJ, Humana Press, pp 181-195, 2011.
27. Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B and Einvik C: MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 32: 1005-1012, 2011.
28. Marimpietri D, Petretto A, Raffaghello L, Pezzolo A, Gagliani C, Tacchetti C, Mauri P, Melioli G and Pistoia V: Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One 8: e75054, 2013.
29. Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, Morgelin M and Belting M: Exosome uptake depends on ERK1/2-heat shock protein 27 signalling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 288: 17713-17724, 2013.
30. Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T and Rak J: Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287: 43565-43572, 2012.
31. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain E, Bengzon J and Belting M: Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 110: 7312-7317, 2013.
32. Bellingham S a, Coleman BM and Hill AF: Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 40: 10937-10949, 2012.
33. Nolte-'t Hoen ENM, Buermans HPJ, Waasdorp M, Stoorvogel W, Wauben MHM and 't Hoen P a C: Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 40: 9272-9285, 2012.
34. Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, Dov A, Dromi N, Elyakim E, Yerushalmi N, Zion O, Lithwick-Yanai G and Sitbon E: Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res 38: 6234-6246, 2010.
35. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan MLG, Karlsson JM, Baty CJ, Gibson G a, Erdos G, Wang Z, Milosevic J, Tkacheva O a, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC and Morelli AE: Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756-766, 2012.
36. Feng S, Cao Z and Wang X: Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta 1836: 197-210, 2013.
37. Wu P-Y, Liao Y-F, Juan H-F, Huang H-C, Wang B-J, Lu Y-L, Yu I-S, Shih Y-Y, Jeng Y-M, Hsu W-M and Lee H: Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma. PLoS One 9: e88795, 2014.
38. Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BKH, Sethi G and Bishayee A: Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 1845: 136-154, 2014.
39. Ara T, Nakata R, Sheard MA, Shimada H, Buettner R, Groshen SG, Ji L, Yu H, Jove R, Seeger RC and DeClerck YA: Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. Cancer Res 73: 3852-3864, 2013.
40. Peirce SK, Findley HW, Prince C, Dasgupta A, Cooper T and Durden DL: The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention. Cancer Chemother Pharmacol 68: 325-335, 2011.
41. Hogarty MD and Maris JM: PI3King on MYCN to improve neuroblastoma therapeutics. Cancer Cell 21: 145-147, 2012.
42. Megison ML, Gillory LA and Beierle EA: Cell survival signaling in neuroblastoma. Anticancer Agents Med Chem 13: 563-575, 2013.
43. Qiao J, Lee S, Paul P, Qiao L, Taylor CJ, Schlegel C, Colon NC and Chung DH: Akt2 regulates metastatic potential in neuroblastoma. PLoS One 8: e56382, 2013.
44. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, González MÁ, Bernad A and Sánchez-Madrid F: Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2: 282, 2011.
45. Feng D, Zhao W-L, Ye Y-Y, Bai X-C, Liu R-Q, Chang L-F, Zhou Q and Sui S-F: Cellular internalization of exosomes occurs through phagocytosis. Traffic 11: 675-687, 2010.